MITO40 INJECTION

MITO40 INJECTION belongs to a group of medicines known as 'anti-cancer' used in cancer therapy. It is most effective in the treatment of advanced metastatic stomach cancer (stomach carcinoma), advanced and/or metastatic breast cancer (breast carcinoma), cancer of the respiratory tract (non-small cell bronchial carcinoma), and advanced cancer of the pancreas (pancreatic carcinoma). Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can attack and destroy surrounding healthy tissue, including organs. Cancer sometimes begins in one body part before spreading to other areas. This process is known as metastasis.

MITO40 INJECTION contains Mitomycin, an anti-cancer medication that is cytotoxic (causes cell death). It works by inhibiting the genetic material's development (DNA) in a cell (cancer cell), thereby stopping cancer cells from dividing. As a result, cancer cell growth and spread stopped or slowed.

Healthcare professionals administer MITO40 INJECTION. It is intended to be used as an injection or infusion into a blood vessel. Depending upon your medical condition, you are advised to take MITO40 INJECTION for as long as your doctor has prescribed it for you. In some cases, you may experience certain common side effects such as nausea, vomiting, hair loss, kidney disorders, fever, and lung disorders. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Before taking MITO40 INJECTION, inform your doctor if you have any infection because MITO40 INJECTION may worsen the infection. Some patients may experience increased sensitivity to light while taking MITO40 INJECTION, and avoiding prolonged exposure to sunlight is recommended. Inform your doctor if you are pregnant as MITO40 INJECTION can cause harmful effects on the unborn baby. Both women and men using this MITO40 INJECTION should use birth control to avoid pregnancy. You should not take this MITO40 INJECTION during breastfeeding. Inform your doctor if you take MITO40 INJECTION. Use the MITO40 INJECTION with caution in elderly patients. Do not take live vaccines three months after your last chemotherapy. Before starting therapy, your doctor may recommend you undergo tests for lung, kidney, and liver function to exclude any diseases.

MITO40 INJECTION belongs to the group of anti-cancer medicines containing Mitomycin. It works by inhibiting the genetic material's development (DNA) in a cell (cancer cell), thereby destroying quickly dividing cells. As a result, the growth and spread of cancer cells in stopped or slowed down.

• Nausea
• Vomiting
• Weakness
• Loss of appetite
• Weight loss
• Increased risk of infection
• Hair loss
• Skin rashes
• Diarrhea
• Fever
• Anemia (low number of red blood cells)
• Thrombocytopenia (decreased number of platelets)
• Leucopenia (decreased number of white blood cells)
• Dyspnoea
• Cough
• Shortness of breath
• Numbness, swelling, and painful redness on palms and soles
• Kidney disorders

Before taking the MITO40 INJECTION, inform your doctor if you have any active infection. Some patients may experience increased sensitivity to light while taking MITO40 INJECTION and avoiding prolonged exposure to sunlight is recommended. Consult your doctor if you are pregnant as MITO40 INJECTION can cause harmful effects on the unborn baby. Both women and men using this MITO40 INJECTION should use birth control to avoid pregnancy. You should not take MITO40 INJECTION during breastfeeding. Use the MITO40 INJECTION with caution in elderly patients. Inform your doctor if you have impaired lung, kidney, or liver function, urinary bladder inflammation, or are undergoing radiation therapy. MITO40 INJECTION is not recommended for use in children and adolescents.

• DOXORUBICIN
• CIPROFLOXACIN
• LEVOFLOXACIN

• Regularly monitor your blood tests to monitor your liver function, electrolyte levels, and blood cell count in your blood.
• Avoid unnecessary or prolonged exposure to sunlight and UV light (such as tanning booths) and wear protective clothing, sunglasses, and sunscreen. MITO40 INJECTION may make your skin sensitive to sunlight.
• MITO40 INJECTION should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking MITO40 INJECTION.
• Consult a doctor immediately if you notice any signs of infection, fever, diarrhoea, chills, etc.

• Eat a healthy diet and exercise regularly to maintain proper weight.
• Avoid smoking and alcohol consumption.
• Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs in your dialy diet.
• Avoid fast, fried, processed meats, refined carbs, and added sugars.
• Get optimal sleep, and rest well.